Tadalafil vs Vardenafil: How Cialis and Levitra Compare
Cialis and Levitra side by side: timing, half-life, side effect tables, the QT warning and what network meta-analyses found.
Tadalafil (Cialis) and vardenafil (Levitra) are both FDA-approved ED tablets, and the biggest practical difference is how long each stays active. The Cialis label says as-needed tadalafil improved erectile function compared with placebo for up to 36 hours after a dose, with a terminal half-life of about 17.5 hours, while the Levitra label gives a half-life of about 4 to 5 hours and says to take it about 60 minutes before sexual activity.12 In pooled trial data tadalafil and vardenafil were the two most effective agents in one large network meta-analysis, with tadalafil ahead on one measure, while a 2026 analysis ranked vardenafil 10 mg above tadalafil 10 mg.34 This guide sets the two labels and the trial evidence side by side.
How do tadalafil and vardenafil differ on the label?
| Tadalafil (Cialis) | Vardenafil (Levitra) | |
|---|---|---|
| Starting dose, as needed | 10 mg; may go to 20 mg or down to 5 mg1 | 10 mg; may go to 20 mg or down to 5 mg2 |
| Timing before sex | Prior to anticipated sexual activity; benefit shown up to 36 hours1 | About 60 minutes before sexual activity2 |
| Time to peak blood level | 30 minutes to 6 hours, median 2 hours1 | 30 minutes to 2 hours, median 60 minutes (fasted)2 |
| Terminal half-life | About 17.5 hours1 | About 4 to 5 hours2 |
| Food | May be taken without regard to food1 | May be taken with or without food; a high-fat meal lowered peak level by 18% to 50%2 |
| Daily low-dose option | Yes, 2.5 mg or 5 mg once daily; also labeled for BPH1 | No; as-needed use, once a day at most2 |
| Maximum frequency | Once per day in most patients1 | Once per day2 |
Both labels say sexual stimulation is needed for either drug to have an effect, and both list nitrates as a contraindication.12
Is tadalafil more effective than vardenafil?
No trial in this review settles it for every man, but the pooled data lean slightly toward tadalafil on some measures and toward vardenafil on others. A 2013 network meta-analysis of 118 trials (31,195 men) found tadalafil more effective than vardenafil on the erectile function domain of the International Index of Erectile Function (mean difference 1.49, 95% CI 0.50 to 2.50), and concluded tadalafil seemed the most effective agent, followed by vardenafil.3 A 2026 dose-specific network meta-analysis of 83 trials (6,029 participants) reported the odds of reaching satisfactory erectile function against placebo as 7.78 for vardenafil 10 mg, 7.13 for tadalafil 20 mg and 3.14 for tadalafil 10 mg.4 The two analyses use different methods and different dose groupings, which is why they do not agree on the ranking. Several authors of the 2026 paper work for Viatris, a sildenafil manufacturer, and the paper says wide confidence intervals mean some estimates are uncertain.4
A 2021 analysis of 179 trials (50,620 patients) placed tadalafil 10 mg and 20 mg among the better profiles, and said sildenafil at low doses and tadalafil should be first options, without singling out vardenafil.5
The preference evidence is thinner. In a 2006 Spanish crossover study of men with mild to moderate ED, 90 evaluable patients took sildenafil 100 mg, vardenafil 20 mg and tadalafil 20 mg in random order. IIEF scores were higher with tadalafil than with vardenafil (P = 0.0002), and 47 patients (52%) preferred tadalafil, 25 (28%) sildenafil and 18 (20%) vardenafil.6 It was open-label and preference-based, and a review of preference trials warns that many have design flaws such as carryover effects that limit how far the results can be generalized.7
Which has more side effects, tadalafil or vardenafil?
The labels report similar kinds of side effects from different trials, and the Levitra label itself warns that rates from one drug's trials cannot be compared directly with another's.21 With that caveat, the tables show:
| Side effect | Tadalafil, as needed (10 mg / 20 mg vs placebo) | Vardenafil (5, 10 or 20 mg vs placebo) |
|---|---|---|
| Headache | 11% / 15% vs 5%1 | 15% vs 4%2 |
| Flushing | 3% / 3% vs 1%1 | 11% vs 1%2 |
| Dyspepsia | 8% / 10% vs 1%1 | 4% vs 1%2 |
| Nasal congestion or rhinitis | 3% / 3% vs 1% (congestion)1 | 9% vs 3% (rhinitis)2 |
| Back pain | 5% / 6% vs 3%1 | 2.0% vs 1.7% (not in the main table)2 |
| Stopped for side effects | 3.1% vs 1.4% placebo1 | 3.4% vs 1.1% placebo2 |
Back pain and muscle aches stand out with tadalafil. The label says they generally begin 12 to 24 hours after dosing and typically resolve within 48 hours.1 Flushing and rhinitis are listed more often with vardenafil. The pooled evidence points the same way: the 2015 trade-off network meta-analysis (72 trials, 20,325 patients for adverse events) found tadalafil 10 mg had the lowest overall rate of adverse events among the starting doses, and vardenafil 10 mg had a similar rate to sildenafil 50 mg with lower efficacy than sildenafil.8 The 2026 analysis likewise found the odds of treatment-related adverse events highest for vardenafil and lowest for tadalafil, again with wide confidence intervals in places.4
Which is safer for the heart: tadalafil or vardenafil?
Both labels advise against use in men for whom sexual activity is inadvisable because of heart disease, and both list recent heart attack and unstable angina among conditions not studied.12 One difference is specific to vardenafil. In a crossover study of 59 healthy men, vardenafil 10 mg and 80 mg produced increases in the heart-rate corrected QT interval similar to the active control moxifloxacin, and the label says men taking class 1A or class III antiarrhythmic drugs, or with congenital QT prolongation, should avoid it.2 The Cialis label contains no equivalent instruction. Both drugs can lower blood pressure with alpha-blockers, and the labels advise starting at the lowest dose when a man is stable on an alpha-blocker.12 Our article on all four ED tablets covers the shared warnings in more detail.
How do dosing schedules differ?
Only tadalafil offers a once-a-day schedule. The Cialis label allows 2.5 mg daily, increased to 5 mg, taken at about the same time every day regardless of sexual activity.1 A randomized trial of 590 men who had only a partial response to as-needed sildenafil, tadalafil or vardenafil found that tadalafil once daily improved erectile function over placebo and gave results comparable to the as-needed drugs, though the trial had no as-needed arm in its blinded phase.9 How the two schedules compare is covered in daily versus as-needed tadalafil. Vardenafil is taken only when needed, about an hour ahead, and no more than once a day.2
The interaction limits also differ in size. With strong CYP3A4 inhibitors such as ketoconazole or ritonavir, as-needed tadalafil is capped at 10 mg and not more than once every 72 hours, while with ritonavir a single 2.5 mg dose of vardenafil should not be exceeded in a 72-hour period.12
Who might lean toward each one?
These are points a prescriber weighs, not rules:
- A long window or spontaneity: tadalafil's 17.5-hour half-life and 36-hour label statement fit men who do not want to time a dose around sex.1
- Prostate symptoms too: tadalafil is also labeled for benign prostatic hyperplasia, which vardenafil is not.1
- Back or muscle aches with a previous tablet: these are listed more often with tadalafil, so a man who had them may want to raise it.1
- Predictable timing: vardenafil's shorter half-life and 60-minute guidance suit planned use, but a high-fat meal lowers its peak level.2
- Heart rhythm history: a history of QT prolongation or antiarrhythmic use is a reason to prefer a different drug than vardenafil.2
If neither suits, sildenafil versus tadalafil and sildenafil versus vardenafil cover the other pairings. Tadalafil is also taken in a sublingual form by some compounded products, which the FDA has not approved; see sublingual versus swallowed ED treatments.
What should a man do if one tablet does not suit?
The Cialis and Levitra labels both start at 10 mg and allow adjustment up or down, so a first dose that causes side effects or falls short is a conversation about dose before it is about switching drugs.12 Pooled data show PDE5 inhibitors as a class beat placebo,3 but a man who responds poorly to one may respond to another, and the label of each lists the same serious warnings: an erection lasting over four hours needs emergency care, and sudden vision or hearing loss means stopping and getting medical help.12 The causes of ED, including vascular disease, diabetes and medicines, also shape the choice; the NIDDK treatment page lists the options beyond tablets.10
Frequently asked questions
Is tadalafil or vardenafil better for ED?
Neither is better for every man. Network meta-analyses disagree on ranking depending on dose and method, one placing tadalafil first and another placing vardenafil 10 mg above tadalafil 10 mg, so the choice usually rests on timing, side effects and other health conditions.
Which lasts longer, Cialis or Levitra?
Cialis lasts longer. Its label reports benefit for up to 36 hours and a half-life of about 17.5 hours, versus a half-life of about 4 to 5 hours for Levitra.
Does vardenafil have more side effects than tadalafil?
In pooled analyses the odds of treatment-related side effects were highest for vardenafil and lowest for tadalafil, though confidence intervals were wide. The labels' tables come from separate trials and cannot be compared directly.
Can I take tadalafil every day but not vardenafil?
Yes. Only tadalafil has a labeled once-daily 2.5 mg or 5 mg schedule for ED. Vardenafil is for as-needed use, no more than once a day.
Why does the Levitra label mention the QT interval?
A crossover study in 59 healthy men found vardenafil increased the corrected QT interval by an amount similar to an active control, so the label advises men with long QT or on certain antiarrhythmics to avoid it.
More comparisons
Part of our guide: ED Pills Compared: Sildenafil, Tadalafil, Vardenafil and Avanafil
Sources
- Eli Lilly. CIALIS (tadalafil) prescribing information. DailyMed, U.S. National Library of Medicine.
- LEVITRA (vardenafil hydrochloride) prescribing information. DailyMed, U.S. National Library of Medicine.
- Yuan J, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013. PubMed 23395275.
- Salonia A, et al. A comparative evaluation of on-demand phosphodiesterase-5 inhibitor efficacy in erectile dysfunction treatment: a systematic review and network meta-analysis of double-blind, placebo-controlled, randomized trials. J Sex Med. 2026. PubMed 42296271.
- Madeira CR, et al. Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis. World J Urol. 2021. PubMed 32388784.
- Tolrà JR, et al. Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors. J Sex Med. 2006. PubMed 16942534.
- Mulhall JP, Montorsi F. Evaluating preference trials of oral phosphodiesterase 5 inhibitors for erectile dysfunction. Eur Urol. 2006. PubMed 16263207.
- Chen L, et al. Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis. Eur Urol. 2015. PubMed 25817916.
- Kim E, et al. Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil. Curr Med Res Opin. 2015. PubMed 25455432.
- National Institute of Diabetes and Digestive and Kidney Diseases. Erectile Dysfunction: Treatment. National Institutes of Health. Accessed October 24, 2026.
- Pfizer. VIAGRA (sildenafil citrate) prescribing information. DailyMed, U.S. National Library of Medicine.